JP2013542204A5 - - Google Patents

Download PDF

Info

Publication number
JP2013542204A5
JP2013542204A5 JP2013532015A JP2013532015A JP2013542204A5 JP 2013542204 A5 JP2013542204 A5 JP 2013542204A5 JP 2013532015 A JP2013532015 A JP 2013532015A JP 2013532015 A JP2013532015 A JP 2013532015A JP 2013542204 A5 JP2013542204 A5 JP 2013542204A5
Authority
JP
Japan
Prior art keywords
ethylcarbamoylamino
benzothiazol
pyrimidin
piperidine
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013532015A
Other languages
English (en)
Japanese (ja)
Other versions
JP5864589B2 (ja
JP2013542204A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2011/001284 external-priority patent/WO2012045124A1/en
Publication of JP2013542204A publication Critical patent/JP2013542204A/ja
Publication of JP2013542204A5 publication Critical patent/JP2013542204A5/ja
Application granted granted Critical
Publication of JP5864589B2 publication Critical patent/JP5864589B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013532015A 2010-10-08 2011-10-07 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類 Expired - Fee Related JP5864589B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39116310P 2010-10-08 2010-10-08
US61/391,163 2010-10-08
PCT/AU2011/001284 WO2012045124A1 (en) 2010-10-08 2011-10-07 Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls

Publications (3)

Publication Number Publication Date
JP2013542204A JP2013542204A (ja) 2013-11-21
JP2013542204A5 true JP2013542204A5 (https=) 2014-11-27
JP5864589B2 JP5864589B2 (ja) 2016-02-17

Family

ID=45925612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013532015A Expired - Fee Related JP5864589B2 (ja) 2010-10-08 2011-10-07 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類

Country Status (6)

Country Link
US (1) US9181234B2 (https=)
EP (1) EP2625178A4 (https=)
JP (1) JP5864589B2 (https=)
CN (1) CN103249732B (https=)
AU (1) AU2011313820A1 (https=)
WO (1) WO2012045124A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012205415B2 (en) 2011-01-14 2017-02-02 Spero Therapeutics, Inc. Pyrimidine gyrase and topoisomerase IV inhibitors
CN103384665B (zh) 2011-01-14 2018-01-09 斯派罗吹耐姆公司 制备促旋酶和拓扑异构酶抑制剂的方法
US8476281B2 (en) 2011-01-14 2013-07-02 Vertex Pharmaceuticals Incorporated Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea
WO2012097270A1 (en) 2011-01-14 2012-07-19 Vertex Pharmaceuticals Incorporated Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea
CN103702994B (zh) 2011-06-20 2016-03-23 沃泰克斯药物股份有限公司 旋转酶和拓扑异构酶抑制剂的磷酸酯
WO2013138860A1 (en) 2012-03-22 2013-09-26 Biota Europe Limited Antibacterial compounds
WO2014015105A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Solid forms of (r)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1h-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
MX2016010057A (es) 2014-02-03 2017-04-27 Spero Gyrase Inc Compuestos antibacterianos.
CN104230991A (zh) * 2014-08-25 2014-12-24 亿腾药业(泰州)有限公司 一种控制福沙吡坦二甲葡胺中钯残留的方法
WO2016119700A1 (en) 2015-01-28 2016-08-04 Jn Therapeutics Substituted imidazo [1, 2-a] pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
CN106167486B (zh) * 2015-05-22 2019-06-14 北京四环制药有限公司 单环类回旋酶和拓扑异构酶iv抑制剂
MD3436461T2 (ro) 2016-03-28 2024-05-31 Incyte Corp Compuși pirolotriazină ca inhibitori TAM
US11168090B2 (en) * 2017-01-18 2021-11-09 Array Biopharma Inc. Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors
CA3057431A1 (en) 2017-03-24 2018-09-27 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
WO2019057946A1 (en) 2017-09-25 2019-03-28 F. Hoffmann-La Roche Ag MULTI-CYCLIC AROMATIC COMPOUNDS AS D-FACTOR INHIBITORS
EP3728228A1 (en) 2017-12-22 2020-10-28 Ravenna Pharmaceuticals, Inc. Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
TW202112767A (zh) 2019-06-17 2021-04-01 美商佩特拉製藥公司 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
WO2021028518A1 (de) * 2019-08-15 2021-02-18 Bayer Aktiengesellschaft Verfahren zur herstellung von 2-(phenylimino)-3-alkyl-1,3-thiazolidin-4-onen
CN115315425B (zh) * 2020-08-14 2025-03-28 上海复旦张江生物医药股份有限公司 一种取代的咪唑并[1,2-a]吡啶-2-基酰胺化合物的制备方法及其中间体
CN115073358B (zh) * 2022-07-21 2023-09-26 安徽德诺医药股份有限公司 一种n-苄基-4-哌啶甲酸乙酯的制备方法
CN118955404A (zh) * 2024-07-30 2024-11-15 凯美克(上海)医药科技有限公司 一种化合物3,5-二溴哒嗪的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
HUP0303494A3 (en) * 2000-12-15 2009-08-28 Vertex Pharma Parmaceutical compositions containing bacterial gyrase inhibitors and uses thereof
US7569591B2 (en) * 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7618974B2 (en) 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US8404852B2 (en) * 2003-01-31 2013-03-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
JPWO2007119833A1 (ja) * 2006-04-14 2009-08-27 武田薬品工業株式会社 含窒素複素環化合物
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
EP2321309A1 (en) * 2008-06-25 2011-05-18 Ranbaxy Laboratories Limited Benzothiazoles and aza-analogues thereof use as antibacterial agents
WO2010100144A1 (en) * 2009-03-04 2010-09-10 Merck Serono S.A. Fused bicyclic compounds as inhibitors for pi3 kinase

Similar Documents

Publication Publication Date Title
JP2013542204A5 (https=)
RU2012130436A (ru) Новое антитромботическое средство
JP2013508404A5 (https=)
JP2020514267A5 (https=)
RU2457207C2 (ru) Активаторы глюкокиназы
JP5864589B2 (ja) 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類
JP2020527560A5 (https=)
RU2012136643A (ru) [5,6]- гетероциклическое соединение
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
RU2016140338A (ru) Азаспиро производные в качестве антагонистов trpm8
JP2018507235A5 (https=)
JP2016520116A5 (https=)
RU2012105284A (ru) Спиро-аминосоединения, пригодные для лечения нарушений сна и лекарственного привыкания
JP2012501312A5 (https=)
JP2011506417A5 (https=)
JP2015517566A5 (https=)
JP2019514878A5 (https=)
JP2015522002A5 (https=)
JP2017535561A5 (https=)
RU2009142851A (ru) Ингибиторы киназы, пригодные для лечения миелопролиферативных заболеваний и других пролиферативных заболеваний
RU2019116251A (ru) Пиразоло[3,4-b]пиридины и имидазо[1,5-b]пиридазины в качестве ингибиторов pde1
JP2017510576A5 (https=)
RU2013136778A (ru) Ингибиторы гистондезацетилазы, композиции и способы их применения
RU2015100942A (ru) Производное пиперидинилпиразолпиридина
JP2014522855A5 (https=)